In contrast, no rHuEpo-mediated activation of pERK, pAKT, or the canonical EpoR pathway constituent, pSTAT5, was observed in any of the tumor samples that were analyzed at any concentration of rHuEpo (the highest concentration employed, 300 U/mL, is represented). Here, EIF2AK3 is linked to neoplasm.